Annual CFO
-$6.14 M
-$10.11 M-254.51%
30 April 2024
Summary:
Champions Oncology annual cash flow from operations is currently -$6.14 million, with the most recent change of -$10.11 million (-254.51%) on 30 April 2024. During the last 3 years, it has fallen by -$4.46 million (-265.08%). CSBR annual CFO is now -194.46% below its all-time high of $6.50 million, reached on 30 April 2022.CSBR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$311.00 K
+$2.13 M+117.13%
31 July 2024
Summary:
Champions Oncology quarterly cash flow from operations is currently $311.00 thousand, with the most recent change of +$2.13 million (+117.13%) on 31 July 2024. Over the past year, it has dropped by -$278.00 thousand (-47.20%). CSBR quarterly CFO is now -92.69% below its all-time high of $4.26 million, reached on 31 January 2022.CSBR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$1.83 M
+$4.30 M+70.10%
31 July 2024
Summary:
Champions Oncology TTM cash flow from operations is currently -$1.83 million, with the most recent change of +$4.30 million (+70.10%) on 31 July 2024. Over the past year, it has increased by +$686.00 thousand (+27.21%). CSBR TTM CFO is now -122.53% below its all-time high of $8.14 million, reached on 31 October 2022.CSBR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -254.5% | -47.2% | +27.2% |
| 3 y3 years | -265.1% | -74.7% | -357.6% |
| 5 y5 years | -429.6% | -13.6% | -218.9% |
CSBR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -194.5% | at low | -92.7% | +107.8% | -122.5% | +70.1% |
| 5 y | 5 years | -194.5% | at low | -92.7% | +107.8% | -122.5% | +70.1% |
| alltime | all time | -194.5% | +36.3% | -92.7% | +107.8% | -122.5% | +80.9% |
Champions Oncology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $311.00 K(-117.1%) | -$1.83 M(-70.1%) |
| Apr 2024 | -$6.14 M(-254.5%) | -$1.82 M(+97.6%) | -$6.14 M(+22.4%) |
| Jan 2024 | - | -$919.00 K(-256.0%) | -$5.01 M(+98.8%) |
| Oct 2023 | - | $589.00 K(-114.8%) | -$2.52 M(-1532.4%) |
| July 2023 | - | -$3.99 M(+476.7%) | $176.00 K(-95.6%) |
| Apr 2023 | $3.97 M(-38.9%) | -$692.00 K(-144.0%) | $3.97 M(-27.3%) |
| Jan 2023 | - | $1.57 M(-52.1%) | $5.46 M(-33.0%) |
| Oct 2022 | - | $3.29 M(-1785.1%) | $8.14 M(+33.8%) |
| July 2022 | - | -$195.00 K(-124.5%) | $6.09 M(-6.3%) |
| Apr 2022 | $6.50 M(-486.5%) | $796.00 K(-81.3%) | $6.50 M(+74.6%) |
| Jan 2022 | - | $4.26 M(+246.7%) | $3.72 M(-1027.9%) |
| Oct 2021 | - | $1.23 M(+468.5%) | -$401.00 K(-46.5%) |
| July 2021 | - | $216.00 K(-110.9%) | -$750.00 K(-55.4%) |
| Apr 2021 | -$1.68 M(-157.9%) | -$1.98 M(-1566.7%) | -$1.68 M(-159.1%) |
| Jan 2021 | - | $135.00 K(-84.6%) | $2.84 M(-4.8%) |
| Oct 2020 | - | $879.00 K(-222.9%) | $2.99 M(+21.0%) |
| July 2020 | - | -$715.00 K(-128.1%) | $2.47 M(-15.0%) |
| Apr 2020 | $2.90 M(+56.0%) | $2.54 M(+812.2%) | $2.90 M(+374.7%) |
| Jan 2020 | - | $279.00 K(-22.5%) | $612.00 K(-60.3%) |
| Oct 2019 | - | $360.00 K(-229.0%) | $1.54 M(+23.7%) |
| July 2019 | - | -$279.00 K(-210.7%) | $1.25 M(-33.0%) |
| Apr 2019 | $1.86 M(-251.9%) | $252.00 K(-79.2%) | $1.86 M(+15.0%) |
| Jan 2019 | - | $1.21 M(+1790.6%) | $1.62 M(+89.6%) |
| Oct 2018 | - | $64.00 K(-81.0%) | $854.00 K(-19.3%) |
| July 2018 | - | $336.00 K(+3633.3%) | $1.06 M(-186.3%) |
| Apr 2018 | -$1.23 M(-56.8%) | $9000.00(-98.0%) | -$1.23 M(+46.5%) |
| Jan 2018 | - | $445.00 K(+66.0%) | -$837.00 K(-57.4%) |
| Oct 2017 | - | $268.00 K(-113.8%) | -$1.97 M(-16.3%) |
| July 2017 | - | -$1.95 M(-589.4%) | -$2.35 M(-17.3%) |
| Apr 2017 | -$2.84 M(-55.7%) | $398.00 K(-158.3%) | -$2.84 M(-25.1%) |
| Jan 2017 | - | -$683.00 K(+488.8%) | -$3.79 M(-1.1%) |
| Oct 2016 | - | -$116.00 K(-95.2%) | -$3.84 M(-39.1%) |
| July 2016 | - | -$2.44 M(+339.5%) | -$6.30 M(-1.6%) |
| Apr 2016 | -$6.41 M(-33.5%) | -$555.00 K(-23.6%) | -$6.41 M(-18.5%) |
| Jan 2016 | - | -$726.00 K(-71.9%) | -$7.86 M(-17.3%) |
| Oct 2015 | - | -$2.58 M(+1.6%) | -$9.51 M(+1.3%) |
| July 2015 | - | -$2.54 M(+26.6%) | -$9.38 M(-2.5%) |
| Apr 2015 | -$9.63 M(+180.5%) | -$2.01 M(-15.5%) | -$9.63 M(+28.5%) |
| Jan 2015 | - | -$2.38 M(-3.4%) | -$7.50 M(+10.6%) |
| Oct 2014 | - | -$2.46 M(-11.8%) | -$6.78 M(+66.2%) |
| July 2014 | - | -$2.79 M(-2330.4%) | -$4.08 M(+18.8%) |
| Apr 2014 | -$3.43 M(-20.2%) | $125.00 K(-107.5%) | -$3.43 M(-27.4%) |
| Jan 2014 | - | -$1.66 M(-784.3%) | -$4.73 M(+29.5%) |
| Oct 2013 | - | $242.00 K(-111.3%) | -$3.65 M(-21.3%) |
| July 2013 | - | -$2.14 M(+83.2%) | -$4.64 M(+7.9%) |
| Apr 2013 | -$4.30 M(-17.7%) | -$1.17 M(+102.4%) | -$4.30 M(-7.6%) |
| Jan 2013 | - | -$578.00 K(-22.7%) | -$4.66 M(+3.7%) |
| Oct 2012 | - | -$748.00 K(-58.6%) | -$4.49 M(-18.3%) |
| July 2012 | - | -$1.81 M(+18.6%) | -$5.50 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2012 | -$5.23 M(+9579.6%) | -$1.52 M(+268.8%) | -$5.23 M(+22.6%) |
| Jan 2012 | - | -$413.00 K(-76.5%) | -$4.26 M(+97.4%) |
| Oct 2011 | - | -$1.76 M(+14.4%) | -$2.16 M(+87.3%) |
| July 2011 | - | -$1.53 M(+175.1%) | -$1.15 M(+2035.2%) |
| Apr 2011 | -$54.00 K(-97.4%) | -$558.00 K(-133.0%) | -$54.00 K(-103.6%) |
| Jan 2011 | - | $1.69 M(-325.3%) | $1.51 M(-231.0%) |
| Oct 2010 | - | -$750.00 K(+72.0%) | -$1.15 M(-24.0%) |
| July 2010 | - | -$436.00 K(-143.3%) | -$1.52 M(-27.7%) |
| Apr 2010 | -$2.10 M(+136.5%) | $1.01 M(-203.3%) | -$2.10 M(-46.8%) |
| Jan 2010 | - | -$976.00 K(-12.4%) | -$3.95 M(+67.6%) |
| Oct 2009 | - | -$1.11 M(+9.4%) | -$2.36 M(+38.7%) |
| July 2009 | - | -$1.02 M(+21.2%) | -$1.70 M(+91.3%) |
| Apr 2009 | -$888.00 K(-212.1%) | -$840.00 K(-236.4%) | -$888.00 K(-775.3%) |
| Jan 2009 | - | $616.00 K(-234.8%) | $131.50 K(-32.0%) |
| Oct 2008 | - | -$457.00 K(+120.8%) | $193.50 K(-62.0%) |
| July 2008 | - | -$207.00 K(-215.3%) | $509.40 K(-35.7%) |
| Apr 2008 | $792.00 K(-1108.9%) | $179.50 K(-73.5%) | $792.00 K(+33.0%) |
| Jan 2008 | - | $678.00 K(-580.5%) | $595.50 K(-657.6%) |
| Oct 2007 | - | -$141.10 K(-286.6%) | -$106.80 K(-771.7%) |
| July 2007 | - | $75.60 K(-544.7%) | $15.90 K(-120.3%) |
| Apr 2007 | -$78.50 K(-16.5%) | -$17.00 K(-30.0%) | -$78.50 K(-4.3%) |
| Jan 2007 | - | -$24.30 K(+32.1%) | -$82.00 K(+0.5%) |
| Oct 2006 | - | -$18.40 K(-2.1%) | -$81.60 K(-5.0%) |
| July 2006 | - | -$18.80 K(-8.3%) | -$85.90 K(-8.6%) |
| Apr 2006 | -$94.00 K(+164.0%) | -$20.50 K(-14.2%) | -$94.00 K(+126.0%) |
| Jan 2006 | - | -$23.90 K(+5.3%) | -$41.60 K(+74.1%) |
| Oct 2005 | - | -$22.70 K(-15.6%) | -$23.90 K(-66.1%) |
| July 2005 | - | -$26.90 K(-184.3%) | -$70.60 K(+98.3%) |
| Apr 2005 | -$35.60 K(-47.4%) | $31.90 K(-614.5%) | -$35.60 K(+28.5%) |
| Jan 2005 | - | -$6200.00(-91.1%) | -$27.70 K(-52.4%) |
| Oct 2004 | - | -$69.40 K(-956.8%) | -$58.20 K(+67.2%) |
| July 2004 | - | $8100.00(-79.6%) | -$34.80 K(-48.6%) |
| Apr 2004 | -$67.70 K(-72.7%) | $39.80 K(-208.4%) | -$67.70 K(-38.7%) |
| Jan 2004 | - | -$36.70 K(-20.2%) | -$110.50 K(-35.6%) |
| Oct 2003 | - | -$46.00 K(+85.5%) | -$171.60 K(-24.1%) |
| July 2003 | - | -$24.80 K(+726.7%) | -$226.20 K(-8.9%) |
| Apr 2003 | -$248.10 K(+658.7%) | -$3000.00(-96.9%) | -$248.20 K(+138.9%) |
| Jan 2003 | - | -$97.80 K(-2.8%) | -$103.90 K(+12.4%) |
| Oct 2002 | - | -$100.60 K(+115.0%) | -$92.40 K(+36.1%) |
| July 2002 | - | -$46.80 K(-133.1%) | -$67.90 K(+107.6%) |
| Apr 2002 | -$32.70 K(-122.6%) | $141.30 K(-263.7%) | -$32.70 K(-136.9%) |
| Jan 2002 | - | -$86.30 K(+13.4%) | $88.50 K(+17.1%) |
| Oct 2001 | - | -$76.10 K(+556.0%) | $75.60 K(-33.0%) |
| July 2001 | - | -$11.60 K(-104.4%) | $112.90 K(-21.9%) |
| Apr 2001 | $144.70 K(-886.4%) | $262.50 K(-364.6%) | $144.60 K(-222.6%) |
| Jan 2001 | - | -$99.20 K(+155.7%) | -$117.90 K(+530.5%) |
| Oct 2000 | - | -$38.80 K(-293.0%) | -$18.70 K(-193.0%) |
| July 2000 | - | $20.10 K | $20.10 K |
| Apr 2000 | -$18.40 K | - | - |
FAQ
- What is Champions Oncology annual cash flow from operations?
- What is the all time high annual CFO for Champions Oncology?
- What is Champions Oncology annual CFO year-on-year change?
- What is Champions Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Champions Oncology?
- What is Champions Oncology quarterly CFO year-on-year change?
- What is Champions Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Champions Oncology?
- What is Champions Oncology TTM CFO year-on-year change?
What is Champions Oncology annual cash flow from operations?
The current annual CFO of CSBR is -$6.14 M
What is the all time high annual CFO for Champions Oncology?
Champions Oncology all-time high annual cash flow from operations is $6.50 M
What is Champions Oncology annual CFO year-on-year change?
Over the past year, CSBR annual cash flow from operations has changed by -$10.11 M (-254.51%)
What is Champions Oncology quarterly cash flow from operations?
The current quarterly CFO of CSBR is $311.00 K
What is the all time high quarterly CFO for Champions Oncology?
Champions Oncology all-time high quarterly cash flow from operations is $4.26 M
What is Champions Oncology quarterly CFO year-on-year change?
Over the past year, CSBR quarterly cash flow from operations has changed by -$278.00 K (-47.20%)
What is Champions Oncology TTM cash flow from operations?
The current TTM CFO of CSBR is -$1.83 M
What is the all time high TTM CFO for Champions Oncology?
Champions Oncology all-time high TTM cash flow from operations is $8.14 M
What is Champions Oncology TTM CFO year-on-year change?
Over the past year, CSBR TTM cash flow from operations has changed by +$686.00 K (+27.21%)